Petersen AM et al. |
[Resistance of Helicobacter pylori to clarithomycin]. |
1998 |
Ugeskr. Laeg. |
pmid:9627511
|
Archimandritis A et al. |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. |
1998 |
J. Intern. Med. |
pmid:9627163
|
Roussel G and Igual J |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9626603
|
Tsuneoka H et al. |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy]. |
1998 |
Kansenshogaku Zasshi |
pmid:9621560
|
Kruppa A et al. |
Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. |
1998 |
Dermatology (Basel) |
pmid:9621142
|
Torresani C |
Clarithromycin: a new perspective in rosacea treatment. |
1998 |
Int. J. Dermatol. |
pmid:9620480
|
Fischer BP et al. |
[Tsutsugamushi fever. Rare rickettsiosis after a stay in the Philippines]. |
1998 |
Dtsch. Med. Wochenschr. |
pmid:9615696
|
Lilley LL and Guanci R |
A dangerous combination. |
1998 |
Am J Nurs |
pmid:9612423
|
Ramon PM et al. |
[Uveitis, arthralgia and pseudo-jaundice in a HIV seronegative patient due to rifabutin]. |
1998 |
Rev Mal Respir |
pmid:9608993
|
Gavura SR and Nusinowitz S |
Leukocytoclastic vasculitis associated with clarithromycin. |
1998 |
Ann Pharmacother |
pmid:9606474
|
Moayyedi P et al. |
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. |
1998 |
J. Gastroenterol. |
pmid:9605943
|
Doherty TM and Sher A |
IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. |
1998 |
J. Immunol. |
pmid:9605144
|
Harris A |
Current regimens for treatment of Helicobacter pylori infection. |
1998 |
Br. Med. Bull. |
pmid:9604443
|
Fujita K et al. |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics]. |
1998 |
Jpn J Antibiot |
pmid:9597505
|
Miyamoto N et al. |
[Test to set dosages for long-term administration of clarithromycin to treat chronic paranasal sinusitis]. |
1998 |
Jpn J Antibiot |
pmid:9597498
|
Sasa K et al. |
[Antineoplastic therapeutic effect of clarithromycin in rats]. |
1998 |
Jpn J Antibiot |
pmid:9597492
|
Yano S et al. |
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system]. |
1998 |
Jpn J Antibiot |
pmid:9597491
|
Kokubo Y et al. |
[Effect of clarithromycin on experimental pulmonary metastasis]. |
1998 |
Jpn J Antibiot |
pmid:9597488
|
Ueta K et al. |
[Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model]. |
1998 |
Jpn J Antibiot |
pmid:9597487
|
Teramoto S et al. |
[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597486
|
Sakamoto M et al. |
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597485
|
Ieshiro R et al. |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report]. |
1998 |
Jpn J Antibiot |
pmid:9597484
|
Enomoto F et al. |
[Changes in adhesion molecule expressions in neutrophils caused by new macrolide administration]. |
1998 |
Jpn J Antibiot |
pmid:9597482
|
Isono K et al. |
[Effects of macrolide antibiotics on neutrophil infiltration into the airway mucosa and ICAM-1 expression]. |
1998 |
Jpn J Antibiot |
pmid:9597480
|
Salgado CG et al. |
[Study on the effects of macrolide antibiotics on the expression of B7-1, B7-2, and CD40 on epidermal Langerhans cells]. |
1998 |
Jpn J Antibiot |
pmid:9597478
|
Iino Y et al. |
[Immunohistochemical study of the paranasal sinus mucosa of patients being treated with macrolide antibiotics--effects of antigen-presenting cells on the expression of a costimulator]. |
1998 |
Jpn J Antibiot |
pmid:9597477
|
Konishi M et al. |
[Log-term administration of clarithromycin as a possible adjuvant therapy of HIV infections]. |
1997 |
Jpn J Antibiot |
pmid:9597467
|
Yanagihara K et al. |
[Analysis of chronic respiratory tract infection by using an intubation model--evaluation based on fluctuations in cytokine content]. |
1997 |
Jpn J Antibiot |
pmid:9597463
|
Mita Y et al. |
[Vitamin D3 induction of differentiation of HL-60 cells to monocyte- like cells and their aggregation--a dynamic culture method and clarithromycin]. |
1997 |
Jpn J Antibiot |
pmid:9597462
|
Takeda H et al. |
[Macrolide antibiotic actions on bacteria and cultured airway cells]. |
1997 |
Jpn J Antibiot |
pmid:9597448
|
Mikasa K et al. |
[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer]. |
1997 |
Jpn J Antibiot |
pmid:9597439
|
Teramoto S et al. |
[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration]. |
1997 |
Jpn J Antibiot |
pmid:9597438
|
Sakamoto M et al. |
[Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer]. |
1997 |
Jpn J Antibiot |
pmid:9597437
|
Kokubo Y et al. |
[Effects of clarithromycin on experimental pulmonary metastasis]. |
1997 |
Jpn J Antibiot |
pmid:9597436
|
Hamada K et al. |
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. |
1997 |
Jpn J Antibiot |
pmid:9597434
|
Sugihara J et al. |
[Efficacy of clarithromycin on chronic paranasal sinusitis--a comparison between children and adult]. |
1997 |
Jpn J Antibiot |
pmid:9597431
|
Koster F |
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS. |
1998 |
Clin. Infect. Dis. |
pmid:9597260
|
van Aarem A et al. |
Recurrent therapy resistant mastoiditis by Mycobacterium cheilonae abscessus, a nontuberculous mycobacterium. |
1998 |
Int. J. Pediatr. Otorhinolaryngol. |
pmid:9596371
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Liu W et al. |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592304
|
Chen S et al. |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592303
|
Sousa C et al. |
[Cholestatic hepatitis probably induced by clarithromycin]. |
1997 |
Gastroenterol. Clin. Biol. |
pmid:9587506
|
Hasegawa M et al. |
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates]. |
1998 |
Kansenshogaku Zasshi |
pmid:9585692
|
Sheu BS et al. |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. |
1998 |
J. Formos. Med. Assoc. |
pmid:9585678
|
Tatsis G et al. |
Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections. |
1998 |
J. Antimicrob. Chemother. |
pmid:9579716
|
Felmingham D et al. |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season. |
1998 |
J. Antimicrob. Chemother. |
pmid:9578171
|
Schwartz H et al. |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. |
1998 |
Am. J. Gastroenterol. |
pmid:9576452
|
Lee KL et al. |
QT prolongation and Torsades de Pointes associated with clarithromycin. |
1998 |
Am. J. Med. |
pmid:9576415
|
Malfertheiner P and Blum AL |
[Helicobacter pylori infection and ulcer]. |
1998 |
Chirurg |
pmid:9576033
|
Griesgraber G et al. |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572891
|
Elliott RL et al. |
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572890
|
Jarboe E et al. |
Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9572027
|
Scott BB |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570263
|
O'Connor HJ et al. |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570262
|
Dal Bo' N et al. |
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks? |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9570242
|
Sonnenberg A et al. |
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. |
1998 |
Arch. Intern. Med. |
pmid:9570170
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Scheen AJ |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. |
1998 |
Rev Med Liege |
pmid:9555183
|
Iwata M et al. |
[Three cases of Fitz-Hugh-Curtis syndrome detected in the early stage by abdominal ultrasonography]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9549331
|
Carnicer J |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?]. |
1998 |
Gastroenterol Hepatol |
pmid:9549199
|
Comet R et al. |
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection]. |
1998 |
Gastroenterol Hepatol |
pmid:9549183
|
Lindsetmo RO et al. |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. |
1998 |
Scand. J. Gastroenterol. |
pmid:9548613
|
Suzuki J et al. |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan. |
1998 |
Helicobacter |
pmid:9546120
|
Treiber G et al. |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. |
1998 |
Helicobacter |
pmid:9546119
|
Oberg KC |
Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. |
1998 Mar-Apr |
Pharmacotherapy |
pmid:9545160
|
Perng CL et al. |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. |
1998 |
Dig. Dis. Sci. |
pmid:9539638
|
Gisbert JP et al. |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. |
1998 |
Med Clin (Barc) |
pmid:9527978
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Collins LA et al. |
Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527783
|
Berquist WE |
New, improved Helicobacter pylori eradication therapy in children. |
1998 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:9523877
|
Alegre Herrera S et al. |
[Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia]. |
1998 |
An Med Interna |
pmid:9522506
|
Laine L and Fendrick AM |
Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment. |
1998 |
Postgrad Med |
pmid:9519040
|
Trivedi S et al. |
Clarithromycin and digoxin toxicity. |
1998 |
Ann. Intern. Med. |
pmid:9518419
|
Fattorini L et al. |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517960
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517944
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Moayyedi P |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin? |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9513823
|
Sato K et al. |
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. |
1998 |
J. Antimicrob. Chemother. |
pmid:9511040
|
Carlson LD et al. |
Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense. |
1998 |
J. Clin. Microbiol. |
pmid:9508306
|
Rosina P et al. |
Fixed drug eruption from clarithromycin. |
1998 |
Contact Derm. |
pmid:9506224
|
Ziering W and McElvaine P |
Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. |
1998 Jan-Feb |
Infection |
pmid:9505188
|
Hocqueloux L et al. |
Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. |
1998 |
Chest |
pmid:9498982
|
Dubois A et al. |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates. |
1998 |
J. Gastroenterol. |
pmid:9497216
|
Kusuhara H et al. |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils. |
1998 |
J. Gastroenterol. |
pmid:9497215
|
Payen MC et al. |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. |
1997 |
Rev Mal Respir |
pmid:9496599
|
Pérez Mota A et al. |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. |
1997 |
Rev Esp Enferm Dig |
pmid:9494375
|
Boixeda de Miquel D |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer]. |
1997 |
Rev Esp Enferm Dig |
pmid:9494374
|
Kondoh K and Hashiba M |
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. |
1998 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9493436
|
Hermon-Taylor J et al. |
Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease. |
1998 |
BMJ |
pmid:9492675
|
Igea JM and Lázaro M |
Hypersensitivity reaction to clarithromycin. |
1998 |
Allergy |
pmid:9491242
|
Ridgway GL et al. |
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. |
1997 |
J. Antimicrob. Chemother. |
pmid:9484871
|
Hotz J |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram]. |
1997 |
Fortschr. Med. |
pmid:9480263
|
Cammarota G et al. |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication. |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9476192
|